HCM
NVO

Horrell Capital Management’s Novo Nordisk NVO Stock Holding History

Horrell Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Sell
20
-50
-71% -$2.15K ﹤0.01% 193
2026
Q1 		$2.57K Hold
70
– – ﹤0.01% 169
2025
Q4 		$3.56K Hold
70
– – ﹤0.01% 164
2025
Q3 		$3.88K Sell
70
-5
-7% -$293 ﹤0.01% 168
2025
Q2 		$5.18K Hold
75
– – ﹤0.01% 160
2025
Q1 		$5.21K Buy
75
+5
+7% +$413 ﹤0.01% 158
2024
Q4 		$6K Hold
70
– – ﹤0.01% 178
2024
Q3 		$8K Hold
70
– – ﹤0.01% 173
2024
Q2 		$10K Hold
70
– – ﹤0.01% 170
2024
Q1 		$9K Buy
+70
New +$8.33K ﹤0.01% 181

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
VFM
Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
ERP
Eldred Rock Partners San Antonio, Texas $465M AUM 48.86% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Horrell Capital Management's NVO Position: Q2 2026 in Review

Horrell Capital Management reduced its Novo Nordisk (NVO) stake by 71% in Q2 2026, selling an estimated $2.15K and leaving 20 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

Horrell Capital Management first reported a position in NVO in Q1 2024 and has held it in 10 quarters since. The position peaked at $10K in Q2 2024. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Horrell Capital Management held 20 shares of Novo Nordisk worth $1K as of Q2 2026.
  • Horrell Capital Management sold 50 Novo Nordisk shares in Q2 2026, an estimated $2.15K.
  • Novo Nordisk made up ﹤0.01% of Horrell Capital Management's portfolio in Q2 2026, its #193 holding.
  • Horrell Capital Management first reported a position in Novo Nordisk in Q1 2024 and has held it in 10 quarters since.
  • Horrell Capital Management's Novo Nordisk position peaked at $10K in Q2 2024.
  • 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Horrell Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.